Providers: $25.5 billion in Provider Relief Fund & American Rescue Plan rural funding is now available. Submit your application by October 26, 2021.

Insurance & Reimbursement

RHC COVID-19 Testing Program and RHC COVID-19 Testing and Mitigation Program

You may apply funds to the remaining expenses or indirect costs attributable to COVID-19 testing, mitigation, and testing and mitigation related expenses (i.e., overhead costs), after netting the other funds received or obligated to be received which offset those expenses. Both the RHC COVID-19 Testing Program and the RHC COVID-19 Testing and Mitigation Program permits reimbursement of marginal increased expenses related to COVID-19 testing and testing related expenses.

HRSA encourages the use of RHC COVID-19 Testing Program funds and RHC COVID-19 Testing and Mitigation Program funds to cover remaining expenses or indirect costs (i.e., overhead costs) so that providers can respond to the coronavirus public health emergency by maintaining health care delivery capacity.

  • You may use any reasonable method of estimating the expenses or indirect costs (i.e., overhead costs) attributable to COVID-19 testing and testing related expenses that are not covered by other payments.
  • You should maintain appropriate records and cost documentation to support these estimates.

RHC COVID-19 Testing and Mitigation Program

You should retain income earned during the period of support—other than income earned as a result of copyrights, patents, or inventions or as a result of the sale of real property, equipment, or supplies—and add to funds committed to the RHC COVID-19 Testing and Mitigation Program and use to further the program.

You are not accountable for program income earned after the period of support.

  • Program income is gross income—earned by a recipient, subrecipient, or a contractor under the RHC COVID-19 Testing and Mitigation Program—directly generated by the program-supported activity or earned as a result of the RHC COVID-19 Testing and Mitigation Program.
  • Program income includes, but is not limited to:
    • Income from fees for services performed
    • Charges for the use or rental of real property, equipment, or supplies acquired under RHC CTM Program
    • Sale of commodities or items fabricated under RHC CTM Program
    • Charges for research resources
    • License fees and royalties on patents and copyrights

RHC COVID-19 Testing Program

RHCs may use funds for:

  • Testing-related activities not reimbursable by insurance coverage
  • Insured patients if the payment received for the COVID-19 test does not fully reimburse the cost.
  • Upfront purchase of supplies necessary to implement and operate a testing program, such as test kits, swabs, and personal protective equipment (PPE).
  • Other startup costs needed to implement a testing program including, but not limited to, retrofitting facilities or hiring staff to carry out COVID-19 testing.

RHCs may NOT use funds to:

  • Reimburse expenses or losses that have been reimbursed from other Provider Relief Fund payments or from the COVID-19 Uninsured Program (i.e., you may not reimburse expenses more than once).
  • Reimburse expenses or losses that have been reimbursed from other sources or that other sources are obligated to reimburse. Other sources of reimbursement include:
    • Insurance providers
    • Medicare
    • Medicaid
    • Other payers (e.g., workers compensation insurance or employer sponsored insurance).

RHCs will:

  • Verify and attest that the patient does not have individual, employer-sponsored, Medicare, or Medicaid coverage, and no other payer will reimburse them for COVID-19 testing for that patient.
  • Maintain records of all subsequent reimbursement or obligated reimbursement to the RHC for COVID-19 testing and/or testing related services by another external payment source, such as public or private insurance coverage.
Date Last Reviewed:  June 2021